Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens
Stephens reaffirmed their overweight rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a research report sent to investors on Monday,Benzinga reports. They currently have a $67.00 target price on the biotechnology company’s stock. Several other analysts also recently weighed in on VCEL. Wall Street Zen downgraded Vericel from a “hold” rating to a […]
More Stories
HHS, FDA, and USDA Address Chronic Disease Epidemic Brought About by Ultra-Processed Foods
By Naveen Athrappully Multiple federal agencies are uniting in an effort to tackle the health risks posed by ultra-processed foods...
MLS, playing without Messi, beats Liga MX 3-1 in All-Star Game
By The Associated Press AUSTIN, Texas (AP) — Sam Surridge, Tai Baribo and Brian White scored goals and Major League Soccer defeated Liga...
USDA Announces Reorganization Plan to Slash Washington Staff by Over 50 Percent
By Tom Ozimek The Trump administration has announced a sweeping overhaul of the U.S. Department of Agriculture (USDA) that will...
US Economy Expands at Fastest Pace This Year, But Factories Slide Into Contraction
By Tom Ozimek The U.S. economy accelerated in July at its fastest pace so far in 2025, according to a...
South Park Season 27: Teeny Tiny Joke, Release Time, Casts, and Where to Watch!
Trump and Satan in Bed? Really? If you thought South Park would go quiet this season, you were wrong. Right...
Johnson Controls International plc (NYSE:JCI) Shares Sold by Choreo LLC
Choreo LLC trimmed its position in Johnson Controls International plc (NYSE:JCI – Free Report) by 22.8% during the 1st quarter,...